Macrodantin and Requip drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Macrodantin (nitrofurantoin, macrocrystalline) and Requip (ropinirole hydrochloride). Common drug interactions include osteopenia among females and multiple sclerosis among males.
The phase IV clinical study analyzes what interactions people have when they take Macrodantin and Requip. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.
What is Macrodantin?
Macrodantin has active ingredients of nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 3,755 Macrodantin users. Check the latest studies of Macrodantin.
What is Requip?
Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.
68 people who take Macrodantin and Requip together, and have interactions are studied.

What are the common drug interactions of Macrodantin and Requip, by gender? *:
female:
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
- Osteoporotic fracture (fracture due to weak bone)
- Pain in jaw
- Pyrexia (fever)
- Stent placement
- Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)
- Swelling face
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Therapeutic response unexpected
male:
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
- Heart rate decreased
- Hypotension (abnormally low blood pressure)
- Hypotonia (low muscle tone)
- Loss of consciousness
- Multi-organ failure (multisystem organ failure)
- Peptic ulcer perforation
- Peripheral swelling
- Pleural effusion (water on the lungs)
What are the common drug interactions of Macrodantin and Requip, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Cholecystitis acute (rapid infection of gallbladder)
- Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
30-39:
n/a
40-49:
- Nephrolithiasis (calculi in the kidneys)
- Gastric bypass
- Hydronephrosis (water inside the kidney)
- Stent placement
- Thyroid cancer
- Accidental needle stick
- Blood potassium decreased
- Circadian rhythm sleep disorder (family of sleep disorders affecting, among other things, the timing of sleep)
- Gastrointestinal inflammation (inflammation of stomach and intestine)
- Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
50-59:
- Renal failure acute (rapid kidney dysfunction)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Septic shock (shock due to blood infection)
- Abasia (inability to walk)
- Abdominal pain upper
- Activities of daily living impaired
- Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
- Adnexa uteri pain
- Balance disorder
- Confusional state
60+:
- Arthralgia (joint pain)
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Skin reaction
- Constipation
- Nausea (feeling of having an urge to vomit)
- Swelling
- Chest pain
- Diarrhoea
- Drug hypersensitivity
- Limb discomfort (discomfort in leg)
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 20.59%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 9 people, 13.24%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 13.24%
- Pain: 6 people, 8.82%
- Hereditary Angioedema (recurrent episodes of severe swelling): 5 people, 7.35%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 7.35%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Macrodantin and Requip?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Macrodantin (3,755 reports)
- Requip (22,950 reports)
Browse all drug interactions of Macrodantin and Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Macrodantin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Macrodantin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Requip and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on nitrofurantoin, macrocrystalline and ropinirole hydrochloride (the active ingredients of Macrodantin and Requip, respectively), and Macrodantin and Requip (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Valsartan and Caffeine - 4 seconds ago
- Could Rilpivirine cause Aspartate Aminotransferase Increased? - 9 seconds ago
- Could Pravastatin Sodium cause Nausea? - 23 seconds ago
- Could Zopiclone cause Complement Factor C4 Decreased? - 24 seconds ago
- Could Furosemide cause Cardiac Flutter? - 25 seconds ago
- Could Taxotere cause Balance Disorder? - 55 seconds ago
- Drug interactions of Amitiza and Fish Oil - 58 seconds ago
- Osteopenia and Presyncope - a minute ago
- Could Symbicort cause Appetite Disorder? - a minute ago
- Could Zyloprim cause Malaise? - a minute ago